PMV Pharmaceuticals (PMVP) Return on Equity [ROE] (2020 - 2026)
PMV Pharmaceuticals' Return on Equity [ROE] was -94.34% in Q2 2026, down 40.55 percentage points from -53.79% a year earlier and down 13.02 percentage points from the prior quarter.
Powered by 
Analysis
PMV Pharmaceuticals (PMVP) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at PMV Pharmaceuticals came in at -55.37%, down 26.15 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of -31.51 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -29.23% in FY2024 (+0.01 pp), -29.24% in FY2023 (-2.80 pp), -26.44% in FY2022 (-9.11 pp) and -17.33% in FY2021 (+6.54 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Equity [ROE] in data going back to Q3 2020.
- Compared with a year earlier, Return on Equity [ROE] has declined for seven straight quarters, with an average year-over-year change of -24.19 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2024 (a gain of 10.20 percentage points); the worst was Q1 2026 (a drop of 45.11 percentage points).
- Per Business Quant data, PMVP's Return on Equity [ROE] in the three quarters before Q2 2026 was -81.32% (Q1 2026), -68.89% (Q4 2025) and -63.23% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | PMV Pharmaceuticals | 89.28 Mn | -325.89 Mn | - | -94.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -94.34% |
| Mar 31, 2026 | -81.32% |
| Dec 31, 2025 | -68.89% |
| Sep 30, 2025 | -63.23% |
| Jun 30, 2025 | -53.79% |
| Mar 31, 2025 | -36.21% |
| Dec 31, 2024 | -31.40% |
| Sep 30, 2024 | -24.97% |
| Jun 30, 2024 | -22.89% |
| Mar 31, 2024 | -29.70% |
| Dec 31, 2023 | -29.77% |
| Sep 30, 2023 | -31.86% |
| Jun 30, 2023 | -33.10% |
| Mar 31, 2023 | -31.08% |
| Dec 31, 2022 | -28.91% |
| Sep 30, 2022 | -26.88% |
| Jun 30, 2022 | -24.30% |
| Mar 31, 2022 | -21.54% |
| Dec 31, 2021 | -18.26% |
| Sep 30, 2021 | -15.07% |
API Access
PMV Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PMVP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PMVP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PMVP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();